GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » EV-to-FCF

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) EV-to-FCF : 44.16 (As of Apr. 24, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Wanbangde Pharmaceutical Holding Group Co's Enterprise Value is ¥4,561 Mil. Wanbangde Pharmaceutical Holding Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥103 Mil. Therefore, Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF for today is 44.16.

The historical rank and industry rank for Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF or its related term are showing as below:

SZSE:002082' s EV-to-FCF Range Over the Past 10 Years
Min: -242.68   Med: -15.64   Max: 1025.97
Current: 43.21

During the past 13 years, the highest EV-to-FCF of Wanbangde Pharmaceutical Holding Group Co was 1025.97. The lowest was -242.68. And the median was -15.64.

SZSE:002082's EV-to-FCF is ranked worse than
71.64% of 543 companies
in the Drug Manufacturers industry
Industry Median: 23.43 vs SZSE:002082: 43.21

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-24), Wanbangde Pharmaceutical Holding Group Co's stock price is ¥5.86. Wanbangde Pharmaceutical Holding Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.166. Therefore, Wanbangde Pharmaceutical Holding Group Co's PE Ratio (TTM) for today is 35.30.


Wanbangde Pharmaceutical Holding Group Co EV-to-FCF Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co EV-to-FCF Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.03 -24.47 -36.15 -14.70 -23.79

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.18 -23.79 -200.19 33.77 38.85

Competitive Comparison of Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF falls into.


;
;

Wanbangde Pharmaceutical Holding Group Co EV-to-FCF Calculation

Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4560.697/103.267
=44.16

Wanbangde Pharmaceutical Holding Group Co's current Enterprise Value is ¥4,561 Mil.
Wanbangde Pharmaceutical Holding Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Wanbangde Pharmaceutical Holding Group Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.86/0.166
=35.30

Wanbangde Pharmaceutical Holding Group Co's share price for today is ¥5.86.
Wanbangde Pharmaceutical Holding Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.166.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Wanbangde Pharmaceutical Holding Group Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines